IP Verse

Claudin-6-Specific Immunoreceptors And T Cell Epitopes - EP3126381

The patent EP3126381 was granted to Biontech Cell&Gene Therapies on Feb 16, 2022. The application was originally filed on Mar 30, 2015 under application number EP15712657A. The patent is currently recorded with a legal status of "Patent Maintained As Amended".

EP3126381

BIONTECH CELL&GENE THERAPIES
Application Number
EP15712657A
Filing Date
Mar 30, 2015
Status
Patent Maintained As Amended
Jan 14, 2022
Grant Date
Feb 16, 2022
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

SCHIWECK WEINZIERL KOCH PATENTANWALTE PARTNERSCHAFT MBBOct 16, 2019SCHIWECK WEINZIERL KOCH PATENTANWALTE PARTNERSCHAFT MBB -

Patent Citations (11) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
DESCRIPTIONUS2003118592
DESCRIPTIONUS2003133939
DESCRIPTIONWO9633265
DESCRIPTIONWO9724447
INTERNATIONAL-SEARCH-REPORTEP2103628
INTERNATIONAL-SEARCH-REPORTEP2138576
INTERNATIONAL-SEARCH-REPORTWO2010094499
INTERNATIONAL-SEARCH-REPORTWO2011057788
INTERNATIONAL-SEARCH-REPORTWO2011113546
INTERNATIONAL-SEARCH-REPORTWO2012156018
OPPOSITIONUS2011300144

Non-Patent Literature (NPL) Citations (5) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
OPPOSITION- "CLD6_HUMAN", UniProtKB, (20000530), Database accession no. P56747, URL: UniProt, XP055650814-
OPPOSITION- "Homo sapiens clone DNA73736 CLDN6 (UNQ757) mRNA", European Nucleotide Archive, (20031009), Database accession no. AY358480.1, XP055650833-
OPPOSITION- LAL-NAG, M. et al., "Claudin-6: a novel receptor for CPE-mediated cytotoxicity in ovarian cancer", Oncogenesis, vol. 1, doi:10.1038/oncsis.2012.32, (20121112), page e33, XP055071624
OPPOSITION- VONDERHEIDE, R. H. et al., "Engineering T cells for cancer: our synthetic future", Immunol Rev., (20140100), vol. 257, no. 1, pages 7 - 13, XP055650804
OPPOSITION- MEERTENS, L. et al., "The Tight Junction Proteins Claudin-1, -6, and -9 Are Entry Cofactors for Hepatitis C Virus", J. Virol., (20080400), vol. 82, no. 7, pages 3555 - 3560, XP055650808

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents